Thank you, Jason. I’m pleased to share more details on the two transformative deals that we completed over the past few weeks. First, I want to touch on Forest Investments. On December 30, we sold 61% of our majority ownership interest in Forest to an affiliate of JPMorgan for over $18 million. In addition to the sale, we received a right to put our remaining 19% interest in Forest for nearly $27 million. We exercised a put right on January 17, bringing our aggregate cash proceeds to approximately $45 million. Next, on January 3, we sold our majority interest in the Durable Medical Equipment business to a subsidiary of Quipt for a total purchase price of $80 million. After repayment of obligations, we received approximately $26 million in cash as well as just over 346,000 shares of Quipt common stock. Please refer to Slide 6 of the investor presentation to view the bridge from the purchase price to our net cash proceeds. As a result of these transactions, we realized material gains on those investments, generated significant value for Great Elm’s shareholders and added over $70 million of cash for the holding company’s balance sheet. This enables us to focus all of our resources towards scaling our alternative asset management business currently anchored by our publicly traded BDC Great Elm Capital Corp. and our private industrial link, Monomoy Properties. We are very pleased at the successful outcome, and we have been hard at work to source and evaluate organic and inorganic growth opportunities. Along with the transactions and streamline structure, we also continue to generate solid performance with our current operations. In the second quarter of fiscal 2023, revenues were up 84% year-over-year, driven by higher AUM and management fees related to GECC and Monomoy. Assets under management of $619 million as of December 31, 2022 was relatively comparable with the prior quarter-end and up 2% year-to-date, while fee-paying AUM grew to $437 million, up over 2% quarter-to-date and over 7% year-to-date. At Monomoy, we maintain a strong backlog of transactions that have the potential to provide further growth. At GECC, we are focused on prudently deploying capital, including through the new Great Elm healthcare finance partnership with Berkadia. Growth in both vehicles is expected to lead to increased AUM and related fees. As our business continues to scale, growth in AUM will drive increasing management fees and profit, reflecting high incremental margins. Our initiatives to reposition the GECC portfolio and reset the incentive fee bodes well for future performance fee growth. Stepping back, we remain focused on our long-term strategy and we’ll continue to invest in the business to drive sustainable growth. We are well positioned to deploy capital into attractive alternative asset management investment in dislocated markets, thanks to our strong and liquid balance sheet, which holds approximately $90 million in cash on a pro forma basis for the Forest and DME transactions. Beyond our strong fundamentals and constructive growth outlook, we still maintain one important differentiating factor, strong shareholder alignment. Great Elm employees and directors, including funds under their management, collectively own or manage approximately 44% of GEG’s outstanding shares, which reinforces the strong alignment of the interest between management and shareholders. With that, I’ll turn it over to Brent to discuss our financial results for the quarter.